Format

Send to

Choose Destination
Sci Transl Med. 2013 Jun 5;5(188):188lr2. doi: 10.1126/scitranslmed.3005697.

Response to comment on "Drug screening for ALS using patient-specific induced pluripotent stem cells".

Abstract

Our work and the study of Bilican et al. highlight the need for complementary assays to detect subtle phenotypic differences between control and mutant induced pluripotent stem cell lines.

PMID:
23740898
DOI:
10.1126/scitranslmed.3005697
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center